Literature DB >> 10567955

Construction of an optimal destructive sampling design for noncompartmental AUC estimation.

F Vandenhende1, M Comblain, M H Delsemme, W Dewe, W P Hoffman, B Boulanger.   

Abstract

Based on toxicokinetic studies of a destructive sampling design, this work was aimed at selecting the number of time points, their locations, and the number of replicates per time point in order to obtain the most accurate and precise noncompartmental estimate of the area under the concentration-time curve (AUC). From a prior population pharmacokinetic model, the design is selected to minimize the scaled mean squared error of AUC. Designs are found for various sample sizes, number of time points, and a distribution of animals across time points from being very unbalanced to balanced. Their efficiencies are compared both theoretically and based on simulations. An algorithm has been implemented for this purpose using the symbolic resolution and numerical minimization capabilities of Mathematica and an example of its use is provided. This method provides efficient tools for constructing, validating, and comparing optimal sampling designs for destructive sampled toxicokinetic studies.

Mesh:

Year:  1999        PMID: 10567955     DOI: 10.1023/a:1020606006936

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  9 in total

1.  Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC).

Authors:  R D Purves
Journal:  J Pharmacokinet Biopharm       Date:  1992-06

2.  Estimating integrals using quadrature methods with an application in pharmacokinetics.

Authors:  A J Bailer; W W Piegorsch
Journal:  Biometrics       Date:  1990-12       Impact factor: 2.571

Review 3.  Optimal statistical design for toxicokinetic studies.

Authors:  D A Beatty; W W Piegorsch
Journal:  Stat Methods Med Res       Date:  1997-12       Impact factor: 3.021

4.  The variance of a better AUC estimator for sparse, destructive sampling in toxicokinetics.

Authors:  J R Nedelman; E Gibiansky
Journal:  J Pharm Sci       Date:  1996-08       Impact factor: 3.534

5.  Optimal design allocations for estimating area under curves for studies employing destructive sampling.

Authors:  W W Piegorsch; A J Bailer
Journal:  J Pharmacokinet Biopharm       Date:  1989-08

6.  Testing for the equality of area under the curves when using destructive measurement techniques.

Authors:  A J Bailer
Journal:  J Pharmacokinet Biopharm       Date:  1988-06

7.  Experimental design for estimating integrals by numerical quadrature, with applications to pharmacokinetic studies.

Authors:  D Katz; D Z D'Argenio
Journal:  Biometrics       Date:  1983-09       Impact factor: 2.571

8.  Optimal sampling times for pharmacokinetic experiments.

Authors:  D Z D'Argenio
Journal:  J Pharmacokinet Biopharm       Date:  1981-12

9.  A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation.

Authors:  K C Yeh; K C Kwan
Journal:  J Pharmacokinet Biopharm       Date:  1978-02
  9 in total
  2 in total

1.  Variability of the model-independent AUC: the one sample per individual case.

Authors:  W Jawień
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

2.  Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug-drug interaction studies for CYP2C9.

Authors:  Kerenaftali Klein; Ivelina Gueorguieva; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-01-21       Impact factor: 2.745

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.